Clearstead Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $2.1M | Buy |
14,067
+591
| +4% | +$82.9K | 0.02% | 379 |
|
|
2026
Q2 | $1.7M | Sell |
13,476
-3,306
| -20% | -$436K | 0.02% | 415 |
|
|
2026
Q1 | $2.34M | Buy |
16,782
+13,228
| +372% | +$1.85M | 0.02% | 331 |
|
|
2025
Q4 | $436K | Sell |
3,554
-68
| -2% | -$8.26K | 0.01% | 699 |
|
|
2025
Q3 | $402K | Sell |
3,622
-1,539
| -30% | -$175K | 0.01% | 696 |
|
|
2025
Q2 | $572K | Buy |
5,161
+2,175
| +73% | +$231K | 0.01% | 577 |
|
|
2025
Q1 | $335K | Buy |
2,986
+292
| +11% | +$30.1K | 0.01% | 678 |
|
|
2024
Q4 | $249K | Sell |
2,694
-428
| -14% | -$38.5K | ﹤0.01% | 787 |
|
|
2024
Q3 | $262K | Sell |
3,122
-85
| -3% | -$6.49K | ﹤0.01% | 767 |
|
|
2024
Q2 | $220K | Buy |
3,207
+5
| +0.2% | +$334 | ﹤0.01% | 794 |
|
|
2024
Q1 | $216K | Sell |
3,202
-57
| -2% | -$4.38K | 0.01% | 453 |
|
|
2023
Q4 | $264K | Sell |
3,259
-20
| -0.6% | -$1.56K | 0.01% | 422 |
|
|
2023
Q3 | $246K | Buy |
3,279
+501
| +18% | +$38.5K | 0.02% | 400 |
|
|
2023
Q2 | $214K | Sell |
2,778
-101
| -4% | -$8.06K | 0.01% | 421 |
|
|
2023
Q1 | $239K | Buy |
2,879
+476
| +20% | +$39.4K | 0.02% | 369 |
|
|
2022
Q4 | $206K | Sell |
2,403
-374
| -13% | -$29.6K | 0.02% | 376 |
|
|
2022
Q3 | $171K | Buy |
2,777
+487
| +21% | +$30.7K | 0.02% | 384 |
|
|
2022
Q2 | $142K | Buy |
2,290
+135
| +6% | +$8.36K | 0.01% | 431 |
|
|
2022
Q1 | $128K | Buy |
2,155
+1,085
| +101% | +$69.4K | 0.01% | 499 |
|
|
2021
Q4 | $78K | Sell |
1,070
-5,576
| -84% | -$384K | 0.01% | 580 |
|
|
2021
Q3 | $464K | Buy |
6,646
+196
| +3% | +$13.8K | 0.03% | 249 |
|
|
2021
Q2 | $444K | Buy |
6,450
+131
| +2% | +$8.75K | 0.03% | 242 |
|
|
2021
Q1 | $408K | Sell |
6,319
-406
| -6% | -$26.2K | 0.03% | 241 |
|
|
2020
Q4 | $392K | Buy |
6,725
+526
| +8% | +$31.7K | 0.04% | 228 |
|
|
2020
Q3 | $392K | Sell |
6,199
-312
| -5% | -$21.6K | 0.04% | 210 |
|
|
2020
Q2 | $501K | Buy |
6,511
+5,631
| +640% | +$432K | 0.06% | 174 |
|
|
2020
Q1 | $66K | Buy |
+880
| New | +$60.8K | 0.01% | 371 |
|
|
2017
Q3 | – | Sell |
-3,455
| Closed | -$245K | – | 251 |
|
|
2017
Q2 | $245K | Sell |
3,455
-965
| -22% | -$64.2K | 0.04% | 208 |
|
|
2017
Q1 | $300K | Buy |
4,420
+833
| +23% | +$58.6K | 0.04% | 178 |
|
|
2016
Q4 | $257K | Buy |
+3,587
| New | +$267K | 0.04% | 181 |
|
Other funds holding GILD
Clearstead Advisors's GILD Position: Q3 2026 in Review
Clearstead Advisors increased its Gilead Sciences (GILD) stake by 4.4% in Q3 2026, buying an estimated $82.9K and bringing the position to 14,067 shares worth $2.1M. The position accounts for 0.02% of the portfolio, ranked #379.
Clearstead Advisors first reported a position in GILD in Q4 2016 and has held it in 30 quarters since. The position peaked at $2.34M in Q1 2026. 2,341 funds tracked by Wall St. Rank hold GILD as of Q3 2026.
- Clearstead Advisors held 14,067 shares of Gilead Sciences worth $2.1M as of Q3 2026.
- Clearstead Advisors bought 591 Gilead Sciences shares in Q3 2026, an estimated $82.9K.
- Gilead Sciences made up 0.02% of Clearstead Advisors's portfolio in Q3 2026, its #379 holding.
- Clearstead Advisors first reported a position in Gilead Sciences in Q4 2016 and has held it in 30 quarters since.
- Clearstead Advisors's Gilead Sciences position peaked at $2.34M in Q1 2026.
- 2,341 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.
Based on Clearstead Advisors's 13F filing for Q3 2026, filed 6 Nov 2026.